Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adaptive Biotechnologies Corp (NQ: ADPT )

4.605 -0.175 (-3.66%)
Streaming Delayed Price Updated: 12:11 PM EDT, Sep 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 417,596
Open 4.720
Bid (Size) 4.600 (9)
Ask (Size) 4.610 (1)
Prev. Close 4.780
Today's Range 4.500 - 4.750
52wk Range 2.280 - 6.340
Shares Outstanding 144,311,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Adaptive Announces IVDR Certification for clonoSEQ® in European Union
clonoSEQ is the first IVDR-certified test to detect minimal residual disease in patients with lymphoid malignancies 
From Adaptive Biotechnologies
Via GlobeNewswire
Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
From Adaptive Biotechnologies
Via GlobeNewswire

Performance

YTD
-3.46%
-3.46%
1 Month
+0.33%
+0.33%
3 Month
+43.91%
+43.91%
6 Month
+38.29%
+38.29%
1 Year
-11.10%
-11.10%

More News

Read More
Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results
From Adaptive Biotechnologies
Via GlobeNewswire
3 Precision Medicine Stocks Tailoring Treatments
Via InvestorPlace
Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
From Adaptive Biotechnologies
Via GlobeNewswire
Cathie Wood-Led Ark Invest Scoops Up $5.16M Worth Of Palantir Shares Amid Raging AI Fervor
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Trading SMID Biotech Stocks In A Volatile Market
Via Talk Markets
Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
From Adaptive Biotechnologies
Via GlobeNewswire
Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
From Adaptive Biotechnologies
Via GlobeNewswire
Mighty Mites: 3 Small-Cap Stocks Packing a Powerful Punch
Via InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Why Adaptive Biotechnologies Topped the Market Today
Via The Motley Fool
ADPT Stock Earnings: Adaptive Biotechnologies Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
From Adaptive Biotechnologies
Via GlobeNewswire
Netflix, ON Semiconductor And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
From Adaptive Biotechnologies
Via GlobeNewswire
Adaptive Biotechnologies Names New CFO Preserves Strong Capital Position
Via Benzinga
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
From Adaptive Biotechnologies
Via GlobeNewswire
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
The 7 Best Penny Stocks to Buy in Q2 2024
Via InvestorPlace
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
From Adaptive Biotechnologies
Via GlobeNewswire
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
From Adaptive Biotechnologies
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.